Skip to content

C Post

6 papers in the library · 118 citations · publishing 1985-1988

Papers

Blockade and reversal of 5-methoxy-N,N-dimethyltryptamine-induced analgesia following noradrenaline depletion.

Brain research April 29, 1985 T Archer, B G Minor, C Post 37 citations

Depleting noradrenaline in rats reversed the pain-relieving effect of the 5-HT agonist 5-MeO-DMT, turning it into pain hypersensitivity in a shock-titration test and completely blocking its antinociceptive effects in hot-plate and tail-flick tests. Depleting serotonin stores did not alter the analgesia caused by 5-MeO-DMT. The results provide strong evidence that central noradrenaline depletion affects the analgesic action of the 5-HT agonist, suggesting an important tonic influence of the noradrenaline system on the descending spinal 5-HT pathway.

(+)-8-OH-DPAT and 5-MeODMT induced analgesia is antagonised by noradrenaline depletion.

Physiology & behavior January 1, 1987 T Archer, E Arweström, B G Minor et al. 32 citations

In rats and mice, two drugs that activate serotonin receptors (8-OH-DPAT and 5-MeODMT) reliably produced pain relief in three different tests (tail-flick, hot-plate, and shock-titration). However, when the animals were pretreated with a toxin that destroys noradrenaline neurons (DSP4) given systemically, or with 6-hydroxydopamine injected directly into the spinal cord, the pain-relieving effects of both drugs were eliminated. In the tail-flick test, 8-OH-DPAT actually caused increased pain sensitivity after spinal cord noradrenaline depletion. Biochemical measurements confirmed that the toxins severely reduced noradrenaline in the spinal cord. The findings suggest that the pain relief from these serotonin drugs depends on intact noradrenaline nerve endings in the spinal cord, pointing to a critical interaction between noradrenaline and serotonin systems in spinal pain processing.

Chronic treatment with antidepressant drugs and the analgesia induced by 5-methoxy-N,N-dimethyltryptamine: attenuation by desipramine.

Acta pharmacologica et toxicologica August 1, 1986 W Danysz, B G Minor, C Post et al. 20 citations

Chronic treatment with the antidepressant desipramine consistently reduced pain relief caused by 5-MeODMT in rats across several pain tests, while chronic amitriptyline sometimes increased that pain relief. Acute antidepressant treatment raised shock thresholds in rats not given 5-MeODMT, but effects differed from chronic treatment. The findings highlight that acute and chronic antidepressant effects on pain perception are distinct.

5-Methoxy-N,N-dimethyltryptamine-induced analgesia is blocked by alpha-adrenoceptor antagonists in rats.

British journal of pharmacology October 1, 1986 T Archer, W Danysz, G Jonsson et al. 16 citations

In rats, drugs that block alpha-2 adrenoceptors (yohimbine and phentolamine) injected into the spinal cord prevented or reduced the pain-relieving effects of a serotonin-like drug (5-MeODMT) in three different pain tests (hot-plate, tail-flick, and shock titration). A different blocker (prazosin) reduced the pain relief in two of the tests but not the third. Yohimbine alone lowered pain thresholds in a dose-dependent way. The results indicate that alpha-2 adrenoceptors interact with serotonin-induced pain relief at the spinal level.

Intrathecal noradrenaline restores 5-methoxy-N,N-dimethyltryptamine induced antinociception abolished by intrathecal 6-hydroxydopamine.

Journal of neural transmission January 1, 1988 B G Minor, M L Persson, C Post et al. 7 citations

In rats, destroying spinal norepinephrine (NA) neurons with 6-hydroxydopamine eliminated the pain-relieving effect of the serotonin receptor agonist 5-MeODMT in three different pain tests. Replacing NA directly into the spinal cord restored the analgesic effect. Chemical analysis confirmed a 95% loss of NA in the spinal cord. Destroying serotonin neurons with 5,7-DHT reduced the analgesic effect in one test. The findings show that NA is necessary for 5-MeODMT to produce analgesia and further clarify how NA modulates serotonin-related pain relief.

Spinal and locus coeruleus noradrenergic lesions abolish the analgesic effects of 5-methoxy-N,N-dimethyltryptamine.

Behavioral and neural biology July 1, 1986 W Danysz, G Jonsson, B G Minor et al. 6 citations

Two experiments on rats show that depleting noradrenaline or serotonin in specific brain and spinal cord regions blocks or reduces pain relief from a drug called 5-MeODMT. Destroying noradrenaline-producing neurons in the locus coeruleus or spinal cord completely eliminated the drug's analgesic effect in three pain tests. Destroying serotonin-producing neurons in the nucleus raphe magnus or spinal cord only partly reduced the effect in two of the tests. The findings indicate that descending noradrenergic and serotonergic pathways interact, likely within the spinal cord, to produce this pain relief.